MindMed reported a net loss of $5.8 million for first 6 months of 2020, has USD $24 million in cash.
Psychedelics
Psychedelics and Cannabis: Part 2, Industry Overlap
Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.
New Psychedelic Research Nonprofit Teams with Johns Hopkins University for Real-World Study on Use of Psilocybin Mushrooms
Unlimited Science, a psychedelics non-profit R&D organization, is collaborating with Johns Hopkins.
MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President
MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.
Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug
Tryp Therapeutics adds a partner to advance its drug manufacturing capabilities.
MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President
MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.
Psychedelics and Cannabis: Part 1, Regulatory Déjà Vu
There are obvious parallels between cannabis and psychedelics decriminalization. Are there are also differences?
Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector
Mydecine's corporate update notes its "world's first" clinical trials initiative for PTSD.
GHP Noetic Science-Psychedelic Pharma Inc. Announces Closing of Initial Public Offering
A new psychedelics company began trading August 11th.
PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands
PharmaDrug takes its first step to begin retail psychedelic sales in the legal market for psychedelic drugs in the Netherlands.
Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin
Revive develops a new tannin-chitosan composite as a psychedelics delivery system.
Canadians LEGALLY Using Psilocybin: A Big Step Forward
For the first time since the 1970's, a small group of Canadians have been granted (federal) permission to legally use psilocybin for medicinal purposes.
MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy
MindMed adds a psychedelics therapy expert to its LSD research program.
4 Palliative Canadians approved for end of life psilocybin therapy through section 56(1) ; First legal medical exemptions for psilocybin in Canada since 1970s
LEGAL use of psilocybin in Canada for the first time in nearly 50 years.
Going To War For Legal Psychedelic Drugs
The need for the medicinal benefits of psychedelic drugs is producing unlikely allies.